PDL BIOPHARMA INC (Y104L)
Institutional ownership reported to the SEC as of Q2 2026, across 27 quarters.
5
Reporting holders
$29.2K
Reported value
0.0%
Held as options
+3
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| DIVERSIFIED TRUST CO | $27.7K | 11,554 | 0.00% | 14q | HELD |
| RHUMBLINE ADVISERS | $1.5K | 612 | 0.00% | 13q | HELD |
| Financial Gravity Companies, Inc. | $0 | 13 | 0.00% | 2q | -60.6% |
| Westside Investment Management, Inc. | $0 | 500 | 0.00% | new | NEW |
| Argent Trust Co | $0 | 41,405 | 0.00% | new | NEW |
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-08-13 | 13G | BRANDES INVESTMENT PARTNERS, LP | 6.2% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 5 | $29.2K | 54,084 | 2 | 0 | 1 | 0.0% |
| Q1 2026 | 2 | $29.2K | 12,166 | 0 | 1 | 0 | 0.0% |
| Q4 2025 | 2 | $28.0K | 11,641 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 2 | $28.0K | 11,641 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 3 | $28.0K | 11,674 | 1 | 0 | 0 | 0.0% |
| Q1 2025 | 2 | $28.0K | 11,641 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 2 | $28.0K | 11,641 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 2 | $28.0K | 11,641 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 2 | $28.0K | 11,641 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 2 | $28.0K | 11,641 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 3 | $130.2K | 53,046 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 3 | $130.2K | 53,046 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 3 | $130.2K | 53,046 | 2 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $26.5K | 11,029 | 1 | 0 | 0 | 0.0% |
| Q1 2022 | 2 | $27.0K | 10,368 | 1 | 0 | 0 | 0.0% |
| Q3 2021 | 3 | $41.1M | 14,487,771 | 1 | 0 | 0 | 0.0% |
| Q2 2021 | 2 | $37.9M | 14,454,212 | 0 | 0 | 0 | 0.0% |
| Q1 2021 | 3 | $36.7M | 14,596,374 | 0 | 1 | 0 | 0.0% |
| Q4 2020 | 30 | $106.3M | 42,172,828 | 5 | 5 | 13 | 0.3% |
| Q3 2020 | 124 | $310.1M | 98,468,905 | 21 | 27 | 50 | 0.1% |
| Q2 2020 | 129 | $280.0M | 96,046,661 | 19 | 31 | 43 | 0.1% |
| Q1 2020 | 124 | $261.3M | 91,787,411 | 14 | 28 | 57 | 0.1% |
| Q4 2019 | 144 | $325.4M | 100,090,917 | 25 | 31 | 58 | 0.2% |
| Q3 2019 | 133 | $215.9M | 99,832,527 | 15 | 32 | 55 | 0.1% |
| Q2 2019 | 138 | $336.9M | 107,078,609 | 8 | 37 | 62 | 0.2% |
| Q1 2019 | 155 | $438.8M | 116,148,800 | 23 | 42 | 50 | 0.1% |
| Q4 2018 | 147 | $352.7M | 121,562,436 | 4 | 0 | 6 | 0.1% |